1. Home
  2.  » 
  3. Catalent News
  4.  » Catalent’s Partner, Amicus, Announces It Has Entered Into A Strategic Partnership With Catalent For Gene Therapy Development And Manufacturing

Catalent’s Partner, Amicus, Announces It Has Entered Into A Strategic Partnership With Catalent For Gene Therapy Development And Manufacturing

The agreement supports clinical and commercial supply needs for Pompe and other lysosomal disease gene therapy programs

Learn More